Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 19Esophageal Squamous Cell Carcinoma 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Ovarian Neoplasms 2Neoplasm, Residual 2Neoplasm Metastasis 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Waldenstrom Macroglobulinemia 1Turcot syndrome 1Testicular Neoplasms 1Surgery 1Stress, Psychological 1Squamous Cell Carcinoma of External Auditory Canal 1Solitary Fibrous Tumor, Pleural 1Seminoma 1Recurrence 1Postoperative Complications 1

Interventions

pembrolizumab 5Nivolumab 3durvalumab 2tremelimumab 1relatlimab 1fludarabine phosphate 1fludarabine 1avelumab 1atezolizumab 1Therapeutics 1Temozolomide 1Surgical Procedures, Operative 1Neoadjuvant Therapy 1Ipilimumab 1Injections 1Docetaxel 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Bevacizumab 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Microsatellite Instability × Neoadjuvant Therapy × 1 year × Clear all
NCT03519412 2026-03-03

ARETHUSA

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 2 Completed
107 enrolled 14 charts
Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡